株式会社カイオム・バイオサイエンス
2 known investors
Chiome is a Japanese biotech venture that discovers and develops antibody drugs targeting unmet medical needs. It works to create drug candidates and build product pipelines through collaboration with external institutions.
Investors · 2
Frequently asked questions
- What does 株式会社カイオム・バイオサイエンス do?
- Chiome is a Japanese biotech venture that discovers and develops antibody drugs targeting unmet medical needs. It works to create drug candidates and build product pipelines through collaboration with external institutions.
- Who are 株式会社カイオム・バイオサイエンス's investors?
- 株式会社カイオム・バイオサイエンス's investors include Fast Track Initiative, SMBC Venture Capital.